Leverage genomic AI to deliver a more accurate and comprehensive genome
Wednesday, April 17
12:10 PM–12:40 PM (ET)
Illumina is leading genomic AI to understand the human genome and provide insights out of large-scale human genomic data. Cutting-edge AI algorithms developed by the Illumina Artificial Intelligence Laboratory have been integrated into the entire genomic workflow resulting in increased accuracy and efficiency in data analysis and interpretation. This integration holds immense potential to bolster drug discovery efficiency, provide deeper clinical insights and more accurate genetic risk prediction. Discover more about Illumina’s proprietary algorithms and their impact from DRAGEN Machine Learning, Emedgene Explainable AI (XAI), and Illumina Connected Annotations PrimateAI-3D and SpliceAI.
Min Li, PhD
Senior Director of Product Management
Illumina
Dr. Min Li is the Senior Director of Product Management at Illumina, where she spearheads the product team responsible for shaping the software and bioinformatics solutions strategy. Her focus encompasses supporting oncology testing, genetic disease testing, reproductive health, and infectious disease testing across all four of Illumina's key clinical segments. Recently she led the effort to drive product strategy with genomic AI embedded into Illumina's end-to-end bioinformatics solutions to unlock the power of the human genome with large-scale genomic data. With over fifteen years of experience in the biotech industry, Dr. Li is a strategic business leader with a deep background in genomic sequencing. Prior to joining Illumina, she held key positions at Amazon, Thermo Fisher Scientific, IDBS, and Partek, where she managed various Next Generation Sequencing products. Dr. Li earned her PhD in Biochemistry from the Ohio State University, cementing her expertise in the field.
Your email address is never shared with third parties.